Intellia Therapeutics

8 followers

‌

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

201-500

Links

Org chart

John Leonard

President & CEO

John Leonard

Collapse

Eliana Clark

EVP, CTO

David Lebwohl

EVP, Chief Medical Officer

Derek Hicks

EVP, Chief Business Officer

Laura Sepp-Lorenzino

EVP, Chief Scientific Officer

Edward Dulac

EVP & CFO

Michael Dube

Vice President, Chief Accounting Officer

Marika St. Amand

SVP, Chief Human Resources Officer

James Basta

EVP, General Counsel & Corporate Secretary

Aron Stein

SVP, Regulatory Affairs

Mary Ferguson

Senior Vice President, Head of Intellectual Property

Yuanxin Xu

SVP, Early Development & Transitional Medicine

Maria Natale

SVP, Commercial

Ray Kelley

Vice President Of Financial Planning Analysis

Emily Williams

Director Corporate Communications

Teams

+38

Research and Development

41 members

+31

Leadership Team

34 members

+19

Corporate Governance and Legal

22 members

+12

Scientific and Technical Positions

15 members

Clinical Operations

11 members

Human Resources and Talent Management

7 members

Similar companies

CRISPR Therapeutics

9 followers

Arrowhead Pharmaceuticals

4 followers

Cerus

2 followers

ImmunityBio

2 followers

Thermo Fisher Scientific

155 followers

Agilent Technologies

63 followers

Myriad Genetics

35 followers

bluebird bio

38 followers

Exact Sciences

15 followers

Natera

13 followers

Cytokinetics

11 followers

Explore companies